Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline

Biological Psychiatry

Volumn 48, Issue 9, 2000, Pages 894-901

  Stahl, Stephen M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antidepressants; Anxiety; Citalopram; Depression; Selective serotonin reuptake inhibitors; Sertraline

Indexed keywords

CITALOPRAM; PLACEBO; SERTRALINE;

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HAMILTON SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; SLEEP DISORDER;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0034333287     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00957-4     Document Type: Article

References (31)

1. The Hamilton Depression Scale; Evaluation of objectivity using logistic models
2. A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression
3. Blockade by newly developed antidepressants of biogenic amine uptake into rat brain synaptosomes
4. Citalopram and fluoxetine in major depression; Comparison of two clinical trials in a psychiatrist setting and in general practice
5. Are patients who are intolerant of one selective serotonin reuptake inhibitor intolerant to another?
6. Effects of psychotropic agents on primary depression
7. A double-blind multicenter trial comparing sertraline and citalopram in patients with major depression treated in general practice
8. Quality of life enjoyment and satisfaction questionnaire; A new measure
9. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression
10. Drug interactions with newer antidepressants; Role of human cytochromes P450
11. The assessment of anxiety states by rating
12. A rating scale for depression
13. The pharmacology of citalopram
14. Dose-dependent inhibition of CYP1A2, CYP2C19, and CYP2D6 by citalopram, fluoxetine, fluvoxamine, and paroxetine
15. Response to an open trial of a second SSRI in major depression
16. Selective serotonin reuptake inhibitors; Relevance of differences in their pharmacological and clinical profiles
17. The comparative psychopharmacology of 5HT re-uptake inhibitors
18. A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression
19. A new depression scale designed to be sensitive to change
20. Citalopram versus fluoxetine; A double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice
21. Replication of factors of psychopathology in interview, ward behaviour, and self-report ratings of hospitalised depressives
22. Antidepressant efficacy of sertraline; A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
23. Sertraline potently displaces 3H-(+)-3-PPP binding to sigma sites in rat brain
24. Basic psychopharmacology of antidepressants (part 1); Antidepressants have seven distinct mechanisms of action
25. Not so selective serotonin reuptake inhibitors
26. Fluoxetine treatment of patient with major depressive disorder who failed initial treatment with sertraline
27. Mirtazapine; Efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder
28. Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?